Please assess the completion status of the following clinical trial:

Trial Title: The University of Michigan PCOS Intervention Using Nutritional Ketosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* We will include women in one PCOS subtype, those having these two symptoms:~  * Hyperandrogenism - (a) If not on current birth control: hyperandrogenism defined as current elevated total testosterone \>= 50 ng/dL or free androgen index \> 1.5 (ratio of testosterone/SHBG x 100) or severe acne or hirsutism (b) if on current birth control: history from the past 10 years of hyperandrogenism defined as past elevated total testosterone \>= 50 ng/dL or free androgen index \> 1.5 (ratio of testosterone/SHBG x 100) or severe acne or hirsutism~ * oligomenorrhea-anovulation defined as spontaneous intermenstrual periods of ≥ 45 days or a total of ≤ 8 menses per year.~Participants must also be:~* overweight or obese (BMI 25-50)~* be 21-40 years old~* have regular access to the internet~* be able to engage in light physical activity~* willing and able to follow the assigned intervention.~Exclusion Criteria:~* a non-English speaker~* inability to complete baseline measurements~* a substance abuse, mental health, or medical condition that would interfere with participation (such as current chemotherapy)~* pregnant or planning to get pregnant in the next 6 months~* type 1 or type 2 diabetes~* baseline aspartate aminotransferase (AST) or alanine aminotransferase (ALT) \> 2 times normal~* baseline renal disease defined as BUN \> 30 mg/dL or serum creatinine \>1.4 mg/dL~* baseline uncorrected thyroid disease (TSH \<0.45 mIU/ML or \>4.5 mIU/ML)~* breastfeeding or less than 6 months post-partum~* planned or history of weight loss surgery~* vegan or vegetarian~* currently enrolled in a weight loss program or other investigative study that might conflict with this research~* taking medications known to cause weight gain or loss~* taking hypoglycemic medications other than metformin or medications known to affect metabolism~* or patients with other etiologies of anovulation and hyperandrogenism, e.g., Cushing's disease, thyroid dysfunction, elevated prolactin levels, signs of congenital adrenal hyperplasia, organic intra cranial lesion such as a pituitary tumor, or suspected adrenal or ovarian tumor secreting androgens.

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- complete diet and lifestyle program (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).